ACE2 and COVID-19: The most commonly used K18-hACE2 model, where hACE2 is expressed under control of the human keratin 18 promotor, in addition to the murine ACE2, appears to be the most susceptible COVID-19 model reported to date using human SARS-CoV-2 isolates (99).